Skip to main content

CITADEL ADVISORS LLC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1423053 MIAMI, FL

Position in ACHV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
18 quarters on record

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Derivatives in ACHV

reported options exposure · as of Mar 31, 2026
CallValue
$596,232
CallShares
202,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,363,972 across 373 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ACHV

Export CSV
38 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $596,232 202,800
2025-12-31 $84,490 17,000
2025-12-31 $466,683 93,900
2025-09-30 $76,230 24,200
2025-09-30 $97,965 31,100
2025-06-30 $62,150 27,500
2025-06-30 $55,862 24,718
2025-03-31 $31,506 11,800
2025-03-31 $5,073 1,900
2025-03-31 $16,614 6,223
2024-12-31 $1,760 500
2024-12-31 $14,784 4,200
2024-12-31 $111,707 31,735
2024-09-30 $28 6
2024-09-30 $17,538 3,700
2024-09-30 $107,124 22,600
2024-06-30 $21,620 4,600
2024-06-30 $305,500 65,000
2024-03-31 $30,485 6,700
2024-03-31 $131,950 29,000
2023-09-30 $29,184 6,787
2023-09-30 $16,340 3,800
2023-09-30 $93,310 21,700
2023-06-30 $76,235 14,689
2023-06-30 $75,255 14,500
2023-06-30 $141,168 27,200
2023-03-31 $16,952 2,493
2023-03-31 $27,200 4,000
2023-03-31 $244,120 35,900
2022-12-31 $7,350 3,000
2022-12-31 $14,945 6,100
2022-12-31 $124,327 50,746
2022-09-30 $115,500 35,000
2022-06-30 $64,782 13,275
2022-06-30 $63,440 13,000
2022-03-31 $380,014 50,200
2021-12-31 $149,429 19,207
2021-03-31 $144,240 12,456